300 F. Supp. 3d 551
S.D. Ill.2018Background
- Xerox acquired ACS in 2010 and sought to commercialize ACS’s Medicaid Management Information System (MMIS) called Health Enterprise, marketing it as a reusable "platform" for state Medicaid systems.
- Between 2012 and 2015 Xerox implemented Health Enterprise for multiple states (e.g., New Hampshire, Alaska, North Dakota, California, Montana, New York) and experienced repeated delays, cost overruns, missed milestones, and ultimately contract disputes/settlements (notably California).
- Lead plaintiff APERS (a public pension fund) sued on behalf of purchasers of Xerox stock during Apr 23, 2012–Oct 27, 2015, alleging Xerox made false/misleading Platform, Success, and Profitability statements that inflated the stock price.
- APERS contended defendants misrepresented that Health Enterprise was a plug‑and‑play, replicable, low‑cost platform; that implementations "were going well"; and that profitability was improving or would improve.
- Defendants moved to dismiss under Fed. R. Civ. P. 12(b)(6). The district court granted dismissal, holding the challenged statements were puffery, non‑actionable opinion/forward‑looking statements (protected where accompanied by cautionary language), or not pleaded as factually false.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the Platform Statements (e.g., "platform," "reusable," "plug‑and‑play") were materially false or misleading | APERS: Xerox touted a transferable, reusable, replicable platform but in truth it was not such a product and required substantial customization/costs | Xerox: Health Enterprise existed as a platform; statements were vague/puffery or forward‑looking and accompanied by cautionary language | Held: Not actionable—Health Enterprise was a platform; many statements were puffery or forward‑looking with meaningful cautionary language and were not pleaded as false |
| Whether Success Statements (claims that implementations "were going well") were false or omitted material adverse facts | APERS: Statements misled investors because implementation problems were ongoing and known to Xerox | Xerox: These were opinions/unevaluative statements, often qualified; there was no duty to disclose additional adverse facts before any contract repudiation | Held: Not actionable—statements were opinion/puffery; no duty to disclose the alleged adverse facts as pled |
| Whether Profitability Statements (current/improving profitability or future margins) were false or forward‑looking with inadequate warnings | APERS: Xerox misrepresented current profitability and future margin prospects | Xerox: Many statements were forward‑looking and contained meaningful cautionary language (PSLRA safe harbor); factual claims (e.g., "flat profitability") were supported by accounting/revenue recognition practices | Held: Not actionable—forward‑looking statements were protected by the PSLRA safe harbor; factual profitability claims were not shown to be false on the pleadings |
| Whether APERS pleaded scienter, materiality, and loss causation sufficiently under the PSLRA and Rule 9(b) | APERS: Alleged facts and later disclosures show defendants knew or were reckless about misstatements causing inflation/losses | Xerox: APERS failed to plead falsity or particularized facts showing scienter or loss causation; many challenged statements are non‑actionable | Held: Court did not reach scienter/loss causation in detail because no actionable misrepresentations were pleaded; dismissal granted |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for Rule 12(b)(6))
- Ashcroft v. Iqbal, 556 U.S. 662 (legal conclusions not accepted as true on a motion to dismiss)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (standard for pleading scienter/inference strength)
- ATSI Communications, Inc. v. Shaar Fund, Ltd., 493 F.3d 87 (heightened pleading standards for securities fraud)
- Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (material misrepresentation/omission standard under Rule 10b‑5)
- Basic Inc. v. Levinson, 485 U.S. 224 (materiality "total mix" standard)
- Rombach v. Chang, 355 F.3d 164 (PSLRA/Rule 9(b) require specification of why statements are misleading)
- Novak v. Kasaks, 216 F.3d 300 (recklessness standard; analyst dissemination does not convert puffery into actionable misstatements)
- Kalnit v. Eichler, 264 F.3d 131 (motive/opportunity and recklessness standards for scienter)
- Slayton v. American Express Co., 604 F.3d 758 (PSLRA safe harbor/cautionary language analysis)